Results 171 to 180 of about 64,206 (312)

ACTH Stimulation Testing Is Often Unnecessary After Appropriate Patient Preparation Prior to Screening Cortisol Measurement

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Context Screening morning serum cortisol is used to select patients for ACTH stimulation testing to diagnose adrenal insufficiency (AI) but may be affected by pre‐analytical factors. Careful consideration to discontinue confounding medications beforehand may preclude the need for subsequent stimulation testing.
Christopher J. Symonds   +2 more
wiley   +1 more source

Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton   +4 more
wiley   +1 more source

Exposure to the Oestrogenic Pollutant 17α‐Ethinyl Estradiol (EE2) Does Not Alter the Behaviour of a Coastal Marine Fish, Cristiceps australis

open access: yesEthology, EarlyView.
Environmental contamination with the synthetic estrogen 17α‐ethinyl estradiol (EE2) is widespread in coastal ecosystems, yet behavioural effects in marine fishes remain poorly understood. We exposed southern crested weedfish (Cristiceps australis) to low and high EE2 concentrations for 14 days and assessed boldness and anxiety using a refuge‐use assay.
Shiho Ozeki   +6 more
wiley   +1 more source

Dynamics of anterior pituitary function in the acute phase of traumatic brain injury: a prospective cohort. [PDF]

open access: yesCrit Care Sci
Cáceres E   +8 more
europepmc   +1 more source

Pharmacokinetics and adverse effects of a long‐acting IM dopamine agonist: Cabergoline in healthy horses

open access: yesEquine Veterinary Education, EarlyView.
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess   +5 more
wiley   +1 more source

An overview of hypopituitarism's causes. [PDF]

open access: yesFront Endocrinol (Lausanne)
Zhang Y, Chen Z, Sun L, Guo W.
europepmc   +1 more source

Home - About - Disclaimer - Privacy